Protect continuity without compromising control
In life sciences, a supply chain delay isn't just a missed order. It can be a patient waiting for therapy.
Supply, quality, batch release, regulatory status, external manufacturing, cold chain, and logistics can't be managed as separate stories. A delay in any one of them can affect product availability and patient care. Life sciences companies need earlier warning, traceable decisions, and controlled ways to change the plan, without creating a second system of record or weakening compliance.
Bristlecone helps pharmaceutical, medtech, diagnostics, and biotech companies modernize planning, platforms, data, and operations with validation and governance designed into the work from the start.
What life sciences supply chain leaders face
Life sciences supply chain leaders carry responsibilities that go beyond cost and service. These are the pressures shaping their priorities:
- Continuity of supply with no margin for error.
- Scarce materials and long lead times, often through external manufacturers.
- Quality and release processes that determine what can actually ship.
- Serialization, traceability, and cold chain requirements across markets.
- Modernization pressure, including ERP replacement, without pausing operations.
Expertise across the life sciences supply chain
Plan
Clinical and commercial supply planning that connects demand, supply, quality, and release status.
Source
Supplier risk and external manufacturing (CMO and CDMO) collaboration.
Make
Production planning with batch, quality, and release data built in.
Deliver
Cold chain visibility, serialization, and track and trace across qualified lanes.
Service
Field inventory, consignment, and installed-base support for medtech and diagnostics.
How Bristlecone helps life sciences companies
Supply Chain Consulting and Transform work are usually paired with Change Management & Adoption, because in regulated environments adoption is part of compliance. Traction shows where new processes are taking hold, Vantage Trace supports traceability, and we modernize ERP and planning platforms, including SAP and Kinaxis, with validation built in.
How life sciences companies measure progress
Progress in life sciences has to show up in both performance and control, so we track both:
- Continuity of supply: backorders, shortages, and service to patients and customers.
- Plan quality: forecast accuracy and plan stability.
- Working capital: inventory levels without compromising safety stock.
- Compliance: traceability completeness, inspection readiness, and controlled change.
- Adoption: proficiency and compliant execution of new processes.
Why life sciences companies choose Bristlecone
Here's why many choose us.
- Modernization without pausing patient supply. A global life sciences leader worked with Bristlecone to improve forecast accuracy, working capital, visibility, and customer service while preparing for ERP transformation.
- Adoption treated as a compliance control, with Traction and embedded guidance helping people follow the validated workflow.
- Validation and governance designed in, so new capabilities don't create parallel control systems.
Choose the part of the industry that matches your world
Explore the one closest to yours:
What leaders ask about Life Sciences
Practical answers to the questions that often shape the first conversation.
How do you modernize a life sciences supply chain without compliance risk?+
Build validation, controlled change, data integrity, and traceability into the program from the start, sequence modernization to protect continuity, and treat user adoption as a compliance control rather than a training task.
Can Bristlecone help with external manufacturing (CMO and CDMO) visibility?+
Yes. We help life sciences companies bring contract manufacturers into planning with shared forecasts, capacity data, release status, and clear exception processes.
How should serialization and traceability data connect with batch release and distribution decisions?+
Connect product and lot identifiers with packaging, quality release, order, shipment, and market data so teams can establish status and provenance across trading partners. The supply-chain design also needs exception ownership, data reconciliation, and a tested response for recalls, shortages, or regulatory holds.